Tullia C. Bruno

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite improvements in surgical techniques and combined chemotherapies, the 5-year survival rate for all stages of non-small cell lung cancer (NSCLC) is only 18%. Understanding the function of tumor infiltrating lymphocytes (TILs) in NSCLC patient tumors will contribute to the development of rationally designed treatments and improved statistics. B cells(More)
  • 1